Insider · CIK 0001184126

GLUCK FREDERICK W

Reports to the SEC for 4 companies · THOUSAND OAKS, CA

sec.gov

Transactions

Companies

Filings

CIK

0001184126

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2022-06-15	CTMXCytomX Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+25K sh	—	—	25,000
2021-06-16	CTMXCytomX Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+20K sh	—	—	20,000
2020-06-17	CTMXCytomX Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+20K sh	—	—	20,000
2019-06-19	CTMXCytomX Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+14K sh	—	—	14,000
2019-04-08	CTMXCytomX Therapeutics, Inc.G Gift	Director	GGift	−3,900 sh	—	—	237,015
2019-04-08	CTMXCytomX Therapeutics, Inc.G Gift	Director	GGift	−3,900 sh	—	—	267,743
2019-04-08	CTMXCytomX Therapeutics, Inc.G Gift	Director	GGift	−3,900 sh	—	—	18,211
2018-06-13	CTMXCytomX Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+14K sh	—	—	14,000
2018-03-26	CTMXCytomX Therapeutics, Inc.S Sale	Director	SSale	−5,000 sh	$31.93	−$160K	271,643
2018-03-02	CTMXCytomX Therapeutics, Inc.S Sale	Director	SSale	−16.2K sh	$30.00	−$485K	276,643
2018-02-28	CTMXCytomX Therapeutics, Inc.S Sale	Director	SSale	−3,819 sh	$30.00	−$115K	292,824
2017-12-26	CTMXCytomX Therapeutics, Inc.S Sale	Director	SSale	−5,000 sh	$22.29	−$111K	306,643
2017-10-04	CTMXCytomX Therapeutics, Inc.S Sale	Director	SSale	−10K sh	$24.27	−$243K	311,643
2017-09-26	CTMXCytomX Therapeutics, Inc.S Sale	Director	SSale	−5,000 sh	$17.30	−$86.5K	321,643
2017-06-26	CTMXCytomX Therapeutics, Inc.S Sale	Director	SSale	−5,000 sh	$14.61	−$73.1K	326,643
2017-06-20	CTMXCytomX Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+14K sh	—	—	14,000
2016-08-09	CTMXCytomX Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−17.1K sh	—	—	0
2016-08-09	CTMXCytomX Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+31.8K sh	$1.13	+$36K	179,558
2016-08-09	CTMXCytomX Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+16.6K sh	$0.94	+$15.7K	196,170
2016-08-09	CTMXCytomX Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+27.6K sh	$1.45	+$40K	223,776
2016-08-09	CTMXCytomX Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+17.1K sh	$1.57	+$27K	240,915
2016-08-09	CTMXCytomX Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−31.8K sh	—	—	0
2016-08-09	CTMXCytomX Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−16.6K sh	—	—	0
2016-08-09	CTMXCytomX Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−27.6K sh	—	—	0
2016-06-10	CTMXCytomX Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+14K sh	—	—	14,000
2016-04-05	CTMXCytomX Therapeutics, Inc.J Other	Director	JOther	+17.1K sh	—	—	22,111
2016-04-05	CTMXCytomX Therapeutics, Inc.J Other	Director	JOther	+332K sh	—	—	331,643
2015-10-14	CTMXCytomX Therapeutics, Inc.P Purchase	Director	PPurchase	+5,000 sh	$12.00	+$60K	5,000
2015-10-14	CTMXCytomX Therapeutics, Inc.P Purchase	Director	PPurchase	+10K sh	$12.00	+$120K	147,791
2011-04-25	AMGNAMGEN INCA Award	Director	AAward	+1,828 sh	—	—	17,576
2011-04-25	AMGNAMGEN INC · Nqso (Right to Buy)A Award	Director	AAward	+5,000 sh	$54.69	+$273K	5,000
2010-09-08	AMGNAMGEN INCS Sale	Director	SSale	−800 sh	$52.36	−$41.9K	15,748
2010-08-26	AMGNAMGEN INCS Sale	Director	SSale	−800 sh	$51.76	−$41.4K	16,548
2010-04-26	AMGNAMGEN INCA Award	Director	AAward	+1,711 sh	—	—	17,348
2010-04-26	AMGNAMGEN INC · Nqso (Right to Buy)A Award	Director	AAward	+5,000 sh	$58.43	+$292K	5,000
2009-04-28	AMGNAMGEN INCA Award	Director	AAward	+1,982 sh	—	—	1,982
2009-04-28	AMGNAMGEN INC · Nqso (Right to Buy)A Award	Director	AAward	+5,000 sh	—	—	5,000
2009-01-27	AMGNAMGEN INCS Sale	Director	SSale	−100 sh	$53.37	−$5,337	13,655
2009-01-27	AMGNAMGEN INC · Nqso (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−16K sh	—	—	0
2009-01-27	AMGNAMGEN INCS Sale	Director	SSale	−338 sh	$53.27	−$18K	21,213
2009-01-27	AMGNAMGEN INCS Sale	Director	SSale	−2,462 sh	$53.30	−$131K	18,751
2009-01-27	AMGNAMGEN INCS Sale	Director	SSale	−1,996 sh	$53.33	−$106K	16,755
2009-01-27	AMGNAMGEN INCS Sale	Director	SSale	−2,700 sh	$53.35	−$144K	14,055
2009-01-27	AMGNAMGEN INCS Sale	Director	SSale	−300 sh	$53.36	−$16K	13,755
2009-01-27	AMGNAMGEN INCS Sale	Director	SSale	−100 sh	$53.27	−$5,326.5	21,551
2009-01-27	AMGNAMGEN INCS Sale	Director	SSale	−400 sh	$53.26	−$21.3K	21,651
2009-01-27	AMGNAMGEN INCS Sale	Director	SSale	−7,604 sh	$53.25	−$405K	22,051
2009-01-27	AMGNAMGEN INCM Exercise/Conversion	Director	MExercise/Conversion	+16K sh	$28.97	+$464K	29,655
2006-03-15	AMGNAMGEN INCA Award	Director	AAward	+1,335 sh	—	—	9,684
2006-03-15	AMGNAMGEN INC · NQSO (Right to Buy)A Award	Director	AAward	+5,000 sh	—	—	5,000

Recent filings

Accepted (ET)
Jun 174
GLUCK FREDERICK W0001567619-22-013071
SEC(opens sec.gov)
Jun 174
GLUCK FREDERICK W0001567619-21-012365
SEC(opens sec.gov)
Jun 174
GLUCK FREDERICK W0001567619-20-012300
SEC(opens sec.gov)
Jun 214
GLUCK FREDERICK W0001567619-19-013825
SEC(opens sec.gov)
May 104/A
GLUCK FREDERICK W0001567619-19-010365
SEC(opens sec.gov)
Apr 104
GLUCK FREDERICK W0001567619-19-008682
SEC(opens sec.gov)
Jun 154
GLUCK FREDERICK W0000899243-18-016816
SEC(opens sec.gov)
Mar 274
GLUCK FREDERICK W0001140361-18-015300
SEC(opens sec.gov)
Mar 54
GLUCK FREDERICK W0001140361-18-012114
SEC(opens sec.gov)
Mar 24
GLUCK FREDERICK W0001140361-18-011514
SEC(opens sec.gov)
Dec 284
GLUCK FREDERICK W0001140361-17-047635
SEC(opens sec.gov)
Oct 64
GLUCK FREDERICK W0001140361-17-037760
SEC(opens sec.gov)
Sep 274
GLUCK FREDERICK W0001140361-17-036614
SEC(opens sec.gov)
Jun 274
CytomX Therapeutics, Inc.0001140361-17-026278
SEC(opens sec.gov)
Jun 224
CytomX Therapeutics, Inc.0001140361-17-025786
SEC(opens sec.gov)
Aug 114
CytomX Therapeutics, Inc.0001140361-16-075795
SEC(opens sec.gov)

Companies

Address

ONE AMGEN CENTER DRIVE

THOUSAND OAKS, CA, 91320-1799